Please refer to the attachment

GUJARAT THEMIS BIOSYN LIMITED CIN: L24230GJ1981PLC004878 REGD. OFFICE &FACTORY: 69/C GIDC INDUSTRIAL ESTATE, VAPI – 396 195, DIST. VALSAD, GUJARAT, INDIA TEL: 0260-2430027 / 2400639 E-mail:hrm@gtbl.in.net November 4, 2026 Listing Department Department of Corporate Services National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block-G Phiroze Jeejeebhoy Towers, Dalal Street Bandra Kurla Complex Mumbai 400001 Bandra East, Mumbai 400051 Symbol: GUJTHEM Scrip Code: 506879 Sub.: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’) – Additional Disclosures in relation to the preferential issue. This is with reference to the earlier disclosures made by the Company in respect of the preferential issue as mentioned at Item No. 8 of the Notice dated 02.09.2026 of the Annual General Meeting held on 30.09.2026 (AGM Notice) to read with corrigendum, at which the said special resolution was passed by the shareholders. Further, in connection with the Company's application filed under Regulation 28(1) of the SEBI Listing Regulations for obtaining in-principle approval for the proposed Preferential Issues, and pursuant to discussions and clarifications sought by the Stock Exchanges, the Company hereby provides the following additional disclosures to the shareholders. These disclosures are additional and explanatory in nature and do not alter the material terms of the preferential issue as approved by the Members at the AGM. 1 With reference to the disclosures provided under Point No. 2 on Page Nos. 15 of the AGM Notice, we would like to clarify that the timeline of 12 months mentioned for utilization of issue proceeds should be considered “12 months from date of allotment of shares”. 2 With reference to the disclosures provided under Point No. 15 on Page Nos. 18 & 19 of the AGM Notice, the names of the Ultimate Beneficial Owners for the following proposed allottees are set out below. a) Special Situation India Fund: Mr. Srinath Narasimhan, Mr. Pankaj Kalra, and Mr. Jigar Karania b) India Special Assets Fund III: Mr. Amit Agarwal, Mr. Navin Sambtani, and Mr. Kriti Ghosh c) ISAF III Onshore Fund: Mr. Amit Agarwal, Mr. Navin Sambtani, and Mr. Kriti Ghosh Above persons are considered / identified as UBO for disclosure purpose and should be read with disclosures made in the AGM Notice. MUMBAI OFFICE: Themis House, 11/12 Udyog Nagar, S.V Road, Goregaon (West), Mumbai – 400 104 Tel: 91-22-67607080 / 28757836 Fax: 28746621 / 67607019; E-mail: gtblmumbai@gtbl.in Website Address: www.gtbl.in GUJARAT THEMIS BIOSYN LIMITED CIN: L24230GJ1981PLC004878 REGD. OFFICE &FACTORY: 69/C GIDC INDUSTRIAL ESTATE, VAPI – 396 195, DIST. VALSAD, GUJARAT, INDIA TEL: 0260-2430027 / 2400639 E-mail:hrm@gtbl.in.net 3 With reference to the disclosures provided under Point No. 22 on Page Nos. 21 of the AGM Notice, the certificate issued by Practicing Company Secretary is hosted on the website at https://www.gtbl.in/uploads/investor-relations/pcs-certificate-for-preferential-issue-4827AA96- 6DE9-4FD0-9B86-72DC0736B822.pdf The same certificate is also attached herewith for easy reference. This intimation is being made available for information of the shareholders on the website of the Company at www.gtbl.in Thanking you Yours faithfully For Gujarat Themis Biosyn Limited Vineet Gawankar Company Secretary & Compliance Officer Encl.: As above MUMBAI OFFICE: Themis House, 11/12 Udyog Nagar, S.V Road, Goregaon (West), Mumbai – 400 104 Tel: 91-22-67607080 / 28757836 Fax: 28746621 / 67607019; E-mail: gtblmumbai@gtbl.in Website Address: www.gtbl.in